A hearty solution for acute myeloid leukemia

Acta Pharmacologica Sinica

Volumn 33, Issue 1, 2012, Pages 1-2

  Hung, Yi Ju ^a   Liu, H Eugene ^b,c  

^a Department of Pathology   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ANTILEUKEMIC AGENT; BH3 PROTEIN; CARDENOLIDE DERIVATIVE; CARDIAC GLYCOSIDE; CD34 ANTIGEN; CYTOCHROME C; DIGITOXIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OUABAIN; PYRITHIONE ZINC; UNBS 1450; UNCLASSIFIED DRUG; UNIBIOSCREEN;

ACUTE GRANULOCYTIC LEUKEMIA; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER RISK; CELL METABOLISM; CHEMOSENSITIVITY; CYTOPLASM; DEPOLARIZATION; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG COST; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG SCREENING; DRUG TARGETING; ENZYME INHIBITION; HIGH THROUGHPUT SCREENING; MITOCHONDRION; PHASE 1 CLINICAL TRIAL (TOPIC); PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; REVIEW; RISK REDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CARDIAC GLYCOSIDES; DRUG DESIGN; ENZYME INHIBITORS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LEUKEMIA, MYELOID, ACUTE; OUABAIN;

EID: 84855427669     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.197     Document Type: Review

References (16)

1. Sukhai MA, Spagnuolo PA, Weir S, Kasper J, Patton L, Schimmer AD. New sources of drugs for hematologic malignancies. Blood 2011; 117: 6747-55.
2. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, et al. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. New Engl J Med 2006; 355: 1018-28. (Pubitemid 44343545)
3. Sahra IB, Marchand-Brustel YL, Tanti J-F, Bost F. Metformin in cancer therapy: a new perspective for old antidiabetic drug? Mol Cancer Ther 2010; 9: 1092-9.
4. Stamatopoulos B, Meuleman N, De Bruyn C, Mineur P, Martiat P, Bron D, et al. Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis. Leukemia 2009; 23: 2281-9.
5. Prassas I, Diamandis EP. Novel therapeutic applica tions of cardiac glycosides. Nature Rev Drug Discovery 2008; 7: 926-35.
6. Tailler M, Senovilla L, Lainey E, Thepot S, Metivier D, Sebert M, et al. Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia. Oncogene 2011. doi: 10.1038/onc.2011.521
7. Stenkvist B. Is digitalis a therapy for breast cancer? Oncol Rep 1999; 6: 493-6.
8. Stenkvist B, Pengtsson E, Dahlgvist B, Eriksson O, Jarkrans T, Nordin B. Cardiac glycosides and breast cancer, revisited. New Engl J Med 1982; 306: 484. (Pubitemid 12171682)
9. Haux J, Klepp O, Spigset O, Tretli S. Digitoxin medication and cancer; case control and internal dose-response studies. BMC Cancer 2001; 1: 11.
10. Mekhail T, Kaur H, Ganapathi R, Budd GT, Elson P, Bukowski RM. Phase 1 trial of Anvirzel in patients with refractory solid tumors. Invest New Drugs 2006; 24: 423-7. (Pubitemid 43876078)
11. Kahn MI, Taft B, Rasku MA, Laber D, Chesney J. A phase 2 trial of biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, interferon, and digoxin in melanoma patients. ASCO Chicago 2007.
12. Chonghaile TN, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore VDG, et al. Pretreatment mito chondrial primng correlates with clinical response to cytotoxic chemotherapy. Science 2011; 334: 1129-33.
13. Guzman ML, Neering SL, Upchurch D, Grimes B, Howard DS, Rizzieri DA, et al. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia. Blood 2001; 98: 2301-7.
14. Selden R, Smith TW, Findley W. Ouabain pharma-cokinetics in dog and man: determination by radio-immunoassay. Circulation 1972; 45: 1176-82.
15. Gottlieb SS, Rogowski AC, Weinberg W, Krichten CM, Hamilton BP, Hamlyn JM. Elevated concen-tra tions of endogenous ouabain in patients with congestive heart failure. Circulation 1992; 86: 420-5.
16. Juncker T, Cerella C, Teiten M-H, Morceau F, Schumacher M, Ghelfi J, et al. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells. Biochem Pharmacol 2011; 81: 13-23.